ProteinQure

- 04/06/2025
- Series A
- $11,000,000
ProteinQure is a biotech company focused on the design of novel exotic peptides with broad therapeutic applications. Powered by atomic-level simulations and artificial intelligence, we design dynamic peptides that take drugs straight to their target – outperforming other treatment delivery systems. By daring to deliver therapeutics in a novel way we are changing the game for drug development and bringing hope to patients with previously untreatable diseases.
At ProteinQure, we pride ourselves on our unique, diverse and cross-disciplinary team that brings together experts from experimental & computational biology, machine learning and software engineering.
- Industry Biotechnology Research
- Website https://www.proteinqure.com/
- LinkedIn https://www.linkedin.com/company/proteinqure/
Related People
Lucas SiowCo Founder

We are building a unique deep tech biology company in the heart of downtown Toronto. ProteinQure partners with some of the world's biggest pharma companies to develop novel therapeutics with proprietary computational tools. ProteinQure combines cutting-edge algorithms with wet-lab experiments designed to power them. We are building the tools to unlock the full potential of peptide therapeutics.
We work at the intersection of tension between ambition and collaboration. You need to be ambitious enough to take on the world's hardest problems, but understand your own gaps so that you can collaborate with a wide range of brilliant people to solve those problems.